bioRxivImmunologyPreprint
Tissue-resident regulatory T cells exert dualistic anti-tumour and pro-repair function in the exocrine pancreas
J. Stockis, T. Yip, S. Raghunathan, C. Garcia, S. Lee, C. Simpson, S. Silvain, M. J. Schuijs, J. Araos, S. Png, G. Raddi, O. Bricard, T. Y. So, S. Mack, P. Papadopoulos, A. Sawle, D. I. Jodrell, A. N. J. McKenzie, J. Thaventhiran, M. Clatworthy, G. Biffi, K. Saeb-Parsy, A. Liston, T. Y. F. Halim
Abstract
Regulatory T cells are fundamentally important for maintaining immune homeostasis, and their potent immune-suppressive roles make them attractive immunotherapeutic targets in cancer. Recent work suggests potential functions of tissue-resident Tregs (trTregs) in tissue-repair and epithelial cell homeostasis. Here, we describe a rare population of trTreg in the exocrine pancreas. We show that these cells share common features of trTregs, including expression of the IL-33 receptor ST2 and production of the epithelial growth factor Amphiregulin, and display an oligoclonal T cell receptor repertoire. Using a mouse model of acute pancreatitis, we show that pancreatic Tregs rapidly expand upon release of IL-33 by fibroblasts. Moreover, depletion of Tregs after initiation of pancreatic injury impairs the regeneration of the exocrine parenchyma. This effect is due, in part, through a direct effect of Tregs on acinar cell proliferation. Finally, we show that transient Treg depletion in established orthotopic pancreatic tumours leads to tumour rejection yet provokes long-lasting damages to surrounding exocrine parenchyma. In all, our results demonstrate the tissue-repair capacity of pancreatic Tregs, and highlight a dualistic role of these cells in the pancreatic tumour ecosystem, with their harmful immune-suppressive function in the tumour coupled to a beneficial tissue-repair function in the surrounding tissue.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Immune responses in pancreatic cancer may be restricted byprevalence of activated regulatory T-cells, dysfunctionalCD8+ T-cells, and senescent T-cells
S. Sivakumar, E. Abu-Shah, … M. Dustin·bioRxiv·Jun 20, 2020
- TNFR2 blockade promotes anti-tumoral immune response in PDAC by targeting activated Treg and reducing T cell exhaustion
A. Debesset, C. Pilon, … J. L. Cohen·bioRxiv·Jan 22, 2024
- Pancreas resident macrophage-induced fibrosis has divergent roles in pancreas inflammatory injury and PDAC
J. M. Baer, C. Zuo, … D. G. DeNardo·bioRxiv·Feb 9, 2022
- Tumor-resident regulatory T cells in pancreatic cancer express the αvβ5 integrin as a targetable activation marker
K. Suzuki, Y. Kunisada, … K. N. Sugahara·bioRxiv·May 24, 2023
- Yap/Taz-Activated Tert-Expressing Acinar Cells Are Required for Pancreatic Regeneration
H. N. Suh, M. J. Kim, … J.-I. Park·bioRxiv·Aug 30, 2021
- Interleukin 6 drives durable T cell-mediated immunity to pancreatic cancer
Paige C. Arneson‐Wissink, Alexandra Q. Bartlett, … Aaron J. Grossberg·Cellular and Molecular Gastroenterology and HepatologyPeer-reviewed·Jan 1, 2026